Rapidly-changing treatment landscapes in diseases like lung cancer pose challenges for medical education providers, who need to be more adaptable than ever.
Researchers agree that early detection is the key to optimising the potential success of drug and device therapies – and that these therapies would work most effectively if they were admini
Online patient communities have become a staple part of the healthcare landscape in recent years, presenting the sector with ever greater opportunities to identify, understand and tackle un
Success requires addressing behaviour from the individual’s perspective, as well as a socio-cultural and environmental context, says Andy Stankus, Kantar’s general manager, Health Division.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.